EA199901098A1 - Новый способ - Google Patents

Новый способ

Info

Publication number
EA199901098A1
EA199901098A1 EA199901098A EA199901098A EA199901098A1 EA 199901098 A1 EA199901098 A1 EA 199901098A1 EA 199901098 A EA199901098 A EA 199901098A EA 199901098 A EA199901098 A EA 199901098A EA 199901098 A1 EA199901098 A1 EA 199901098A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
new method
paroxetine
things
structures
Prior art date
Application number
EA199901098A
Other languages
English (en)
Inventor
Марвин Сунгвхан Йу
Виктор Витолд Яцевич
Евгений Шапиро
Original Assignee
Смитклайн Бичам Корпорейшн
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9711095.1A external-priority patent/GB9711095D0/en
Priority claimed from GBGB9714875.3A external-priority patent/GB9714875D0/en
Application filed by Смитклайн Бичам Корпорейшн, Смитклайн Бичам Плс filed Critical Смитклайн Бичам Корпорейшн
Publication of EA199901098A1 publication Critical patent/EA199901098A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Соединения структуры (1) получают путем восстановления соединений структур (2a), (2b), (4a), (4b). Соединения структуры (1), в особенности те, в которых Z представляет собой атом водорода или 3,4-метилендиоксифенильную группу, являются важными промежуточными соединениями, помимо прочего, для пароксетина.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199901098A 1997-05-29 1998-05-29 Новый способ EA199901098A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9711095.1A GB9711095D0 (en) 1997-05-29 1997-05-29 Novel process
GBGB9714875.3A GB9714875D0 (en) 1997-07-15 1997-07-15 Novel process
PCT/US1998/011057 WO1998053824A1 (en) 1997-05-29 1998-05-29 Novel process

Publications (1)

Publication Number Publication Date
EA199901098A1 true EA199901098A1 (ru) 2000-08-28

Family

ID=26311618

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199901098A EA199901098A1 (ru) 1997-05-29 1998-05-29 Новый способ

Country Status (22)

Country Link
US (3) US6489347B1 (ru)
EP (1) EP0986389B1 (ru)
JP (1) JP2002514222A (ru)
CN (1) CN1268889A (ru)
AP (1) AP9901698A0 (ru)
AT (1) ATE279393T1 (ru)
AU (1) AU7708998A (ru)
BG (1) BG104034A (ru)
BR (1) BR9809687A (ru)
CA (1) CA2291251A1 (ru)
DE (1) DE69827000D1 (ru)
EA (1) EA199901098A1 (ru)
HU (1) HUP0003958A3 (ru)
ID (1) ID24383A (ru)
IL (1) IL133140A0 (ru)
NO (1) NO995796L (ru)
NZ (1) NZ501285A (ru)
OA (1) OA11223A (ru)
PL (1) PL337513A1 (ru)
SK (1) SK159899A3 (ru)
TR (1) TR199902929T2 (ru)
WO (1) WO1998053824A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6438585B2 (en) * 1998-05-29 2002-08-20 Research In Motion Limited System and method for redirecting message attachments between a host system and a mobile data communication device
EP1124802A1 (en) * 1998-11-02 2001-08-22 Synthon B.V. Process for producing 4-arylpiperidine-3-carbinols and related compounds
US20010053862A1 (en) * 1998-12-22 2001-12-20 Bruce Ronsen Process for preparing arylpiperidine carbinol intermediates and derivatives
GB9828767D0 (en) * 1998-12-29 1999-02-17 Smithkline Beecham Plc Novel process
IT1313702B1 (it) * 1999-08-02 2002-09-09 Chemi Spa Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
US6833458B2 (en) * 2000-06-05 2004-12-21 Development Center For Biotechnology Practical syntheses of chiral trans-3, 4-disubstituted piperidines and the intermediates
IL156768A0 (en) 2001-01-04 2004-02-08 Ferrer Int Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
AU2002330771A1 (en) 2001-10-22 2003-06-10 Synthon B.V. N-formyl derivatives of paroxetine
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CN112645951A (zh) * 2020-12-23 2021-04-13 上海博栋化学科技有限公司 由长春布宁合成的磺酸锍盐类光产酸剂及其合成方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798432A (en) * 1945-02-27 1957-07-09 Leo T Meister Delay action fuse
US2498432A (en) 1946-07-08 1950-02-21 Hoffmann La Roche 1-branched lower alkyl-4-phenyl-4-acyloxy-piperidines and their acid addition salts
GB1422263A (en) 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4593036A (en) 1984-02-07 1986-06-03 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-[(4-methoxyphenoxy)methyl]-1-methylpiperidine useful as 5-HT potentiator
US4585777A (en) 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
EP0190496A3 (en) * 1984-12-13 1987-05-27 Beecham Group Plc Piperidine derivatives having a gastro-intestinal activity
EP0223334B1 (en) * 1985-08-10 1991-07-10 Beecham Group Plc Process for the preparation of aryl-piperidine carbinols
GB8520154D0 (en) 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
GB8714707D0 (en) 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
DK715988D0 (da) 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
IL98757A (en) 1990-07-18 1997-01-10 Novo Nordisk As Piperidine derivatives their preparation and pharmaceutical compositions containing them
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
GB9305175D0 (en) 1993-03-13 1993-04-28 Smithkline Beecham Plc Novel process
ES2102295B1 (es) 1994-03-18 1998-04-01 Ferrer Int Nuevos compuestos derivados de la n-benzoilmetil-piperidina.
US5856493A (en) 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
US5554383A (en) * 1995-04-06 1996-09-10 Trustees Of Tufts College Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
EP0828735A1 (en) 1995-05-17 1998-03-18 Novo Nordisk A/S Process for preparing 4-aryl-piperidine derivatives
EP0863875B1 (de) 1995-09-07 2003-06-04 F. Hoffmann-La Roche Ag Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz
ES2121685B1 (es) * 1996-04-10 1999-09-16 Vita Invest Sa Procedimiento para la obtencion de (+)-trans-4(4-fluoro-fenil)-3-hidroximetil-1-metilpiperidina.
JP3446468B2 (ja) * 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
EP0812827B1 (en) * 1996-06-13 2009-09-02 Sumitomo Chemical Company, Limited Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation
CA2284732C (en) 1997-04-07 2008-06-17 Georgetown University Analogs of cocaine
EP1124802A1 (en) 1998-11-02 2001-08-22 Synthon B.V. Process for producing 4-arylpiperidine-3-carbinols and related compounds
US6051812A (en) * 1998-11-16 2000-04-18 Walker; Lawrence Snow and ice melting blanket device

Also Published As

Publication number Publication date
BG104034A (en) 2000-11-30
AP9901698A0 (en) 1999-12-31
EP0986389B1 (en) 2004-10-13
NO995796D0 (no) 1999-11-26
WO1998053824A1 (en) 1998-12-03
BR9809687A (pt) 2000-07-11
US6716985B2 (en) 2004-04-06
PL337513A1 (en) 2000-08-28
HUP0003958A2 (hu) 2001-05-28
CN1268889A (zh) 2000-10-04
ATE279393T1 (de) 2004-10-15
SK159899A3 (en) 2000-06-12
OA11223A (en) 2003-06-17
EP0986389A1 (en) 2000-03-22
IL133140A0 (en) 2001-03-19
NZ501285A (en) 2001-10-26
US6489347B1 (en) 2002-12-03
CA2291251A1 (en) 1998-12-03
EP0986389A4 (en) 2001-09-12
TR199902929T2 (xx) 2000-06-21
HUP0003958A3 (en) 2001-06-28
AU7708998A (en) 1998-12-30
DE69827000D1 (de) 2004-11-18
NO995796L (no) 1999-11-26
JP2002514222A (ja) 2002-05-14
US20040147754A1 (en) 2004-07-29
US20020133011A1 (en) 2002-09-19
ID24383A (id) 2000-07-13

Similar Documents

Publication Publication Date Title
EA200300429A1 (ru) Способ получения порошковых композиций
DE69709938T2 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
ES2155844T3 (es) Preparacion de n-alquilcarboxilatos de piperidinilo 3,4,4-trisustituidos e intermedios, utiles como antagonistas de opiaceos.
EA200100022A1 (ru) Композиции с контролируемым высвобождением пароксетина
GT199900055A (es) Nuevas dihidropirimidinas2 heterocìclicamente sustituidas.
EA199901098A1 (ru) Новый способ
DE69813605D1 (de) Benzofuranderivate
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
EA200000094A1 (ru) Способ получения замещенного пергидроизоиндола
EA199800792A1 (ru) Способы получения промежуточных соединений для пестицидов
ES2148858T3 (es) (aminoalquil- y acilaminoalquil-oxi)benciloxiquinolinas, procedimiento para su preparacion y su empleo como antagonistas de receptores de bradiquinina.
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
EA199900027A1 (ru) Способ получения некоторых азациклогексапептидов
EA200100040A1 (ru) Химический синтез морфолиновых производных
EA199900741A1 (ru) Способ получения эпросартана
EA200200969A1 (ru) Способ получения циталопрама
EA199900740A1 (ru) Способ получения эпросартана (варианты)
DK1135517T3 (da) Produktionen af ascorbinsyre ved at anvende gær
EA199900235A1 (ru) Аморфные бензотиофены, способы получения и способы применения
BR9707356A (pt) Composto processo para preparação do mesmo composição fingicida e processo para combater fungos
EA199900772A1 (ru) Способ селективного эпоксидирования для получения лекарственных соединений
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
EA200100131A1 (ru) Способ получения витамина а
EA200100864A1 (ru) Способ получения 1,4,7,10-тетраазациклододекана
EA199700395A1 (ru) Способ получения ингибиторов протеазы вируса иммунодефицита человека